» Articles » PMID: 31136565

Mean Corpuscular Volume Predicts In-Stent Restenosis Risk for Stable Coronary Artery Disease Patients Receiving Elective Percutaneous Coronary Intervention

Overview
Journal Med Sci Monit
Date 2019 May 29
PMID 31136565
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

BACKGROUND The purpose of this study was to analyze predictive performance of MCV in midterm ischemic events among SCAD patients undergoing elective PCI. MATERIAL AND METHODS We retrospectively included 226 consecutive patients with SCAD who received elective PCI. The patients were grouped based on MCV quartile values. The prognostic significance of MCV was assessed using univariate and multivariate Cox proportional hazard regression analyses. RESULTS According to MCV quartile points (87.5 fL, 89.7 fL, and 92.4 fL, respectively), the included patients were divided into 4 groups, with an average follow-up of 34.2 months. There were 28 (48.3%) patients with stent thrombosis in the 1st quartile, 24 (29.1%) in the 2nd quartile, 18 (31.6%) in the 3rd quartile, and 15 (27.8%) in the 4th quartile (log-rank test, P=0.027). Multivariate analysis confirmed that MCV 1st quartile (HRadj=2.047, 95% CI 1.041-4.026; P=0.038), ALT (HRadj=1.013, 95% CI 1.004-1.023; P=0.004) and number of PCI vessels (HRadj=1.198 95% CI 1.013-1.415; P=0.034) were risk factors for ischemic events. The restenosis rate in patients belonging to the MCV 1st quartile was 2 times higher than that in MCV 2nd, 3rd, and 4th quartile groups (P=0.007). CONCLUSIONS MCV value may be independently correlated with restenosis in SCAD patients undergoing PCI. Low MCV predicts high risk of in-stent restenosis.

Citing Articles

D-dimers or more? Assessing the role of laboratory factors in predicting and confirming pulmonary embolism in high-risk orthopedic patients.

Borowski B, Haratym M, Piech P, Jarecki J, Staskiewicz G Pract Lab Med. 2025; 44:e00452.

PMID: 39945000 PMC: 11815958. DOI: 10.1016/j.plabm.2025.e00452.


A systematic review and bioinformatic study on clinical, paraclinical, and genetic factors predisposing to stent restenosis following percutaneous coronary intervention.

Shahsanaei F, Gharibzadeh A, Behrooj S, Abbaszadeh S, Nourmohammadi M BMC Cardiovasc Disord. 2024; 24(1):304.

PMID: 38877398 PMC: 11177414. DOI: 10.1186/s12872-024-03955-3.


The Relationship between Amount of Air Supplied to Radial Artery Compression Device Used after Transradial Procedure and Radial Artery Stenosis.

Kanal Y, Ozkan C Acta Cardiol Sin. 2024; 40(2):200-207.

PMID: 38532819 PMC: 10961642. DOI: 10.6515/ACS.202403_40(2).20231212A.


Predictors of Revascularization in Patients with Unstable Angina.

Budzianowski J, Faron W, Rzezniczak J, Slomczynski M, Hiczkiewicz D, Olejniczak J J Clin Med. 2024; 13(4).

PMID: 38398410 PMC: 10889168. DOI: 10.3390/jcm13041096.


Reticulocyte Hemoglobin as a Screening Test for Iron Deficiency Anemia: A New Cut-Off.

Aedh A, Khalil M, Abd-Elkader A, El-Khawanky M, Alshehri H, Hussein A Hematol Rep. 2023; 15(1):201-211.

PMID: 36975734 PMC: 10048437. DOI: 10.3390/hematolrep15010021.


References
1.
Tefferi A . Anemia in adults: a contemporary approach to diagnosis. Mayo Clin Proc. 2003; 78(10):1274-80. DOI: 10.4065/78.10.1274. View

2.
Cassar A, Holmes Jr D, Rihal C, Gersh B . Chronic coronary artery disease: diagnosis and management. Mayo Clin Proc. 2009; 84(12):1130-46. PMC: 2787400. DOI: 10.4065/mcp.2009.0391. View

3.
Brown R . Determining the cause of anemia. General approach, with emphasis on microcytic hypochromic anemias. Postgrad Med. 1991; 89(6):161-4, 167-70. DOI: 10.1080/00325481.1991.11700925. View

4.
Dangas G, Claessen B, Caixeta A, Sanidas E, Mintz G, Mehran R . In-stent restenosis in the drug-eluting stent era. J Am Coll Cardiol. 2010; 56(23):1897-907. DOI: 10.1016/j.jacc.2010.07.028. View

5.
Raber L, Wohlwend L, Wigger M, Togni M, Wandel S, Wenaweser P . Five-year clinical and angiographic outcomes of a randomized comparison of sirolimus-eluting and paclitaxel-eluting stents: results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE trial. Circulation. 2011; 123(24):2819-28, 6 p following 2828. DOI: 10.1161/CIRCULATIONAHA.110.004762. View